Clinical trial
ILF With/Without Cisplatin for Advanced Gastric Cancer
NCT00320294 · Gachon University Gil Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00320294 |
|---|---|
| Title | ILF With/Without Cisplatin for Advanced Gastric Cancer |
| Official title | A Randomized Trial of Irinotecan, Leucovorin, 5-FU (ILF) Versus ILF Plus Cisplatin (PILF) Combination Chemotherapy in Patients With Advanced Gastric Cancer |
| Lead sponsor | Gachon University Gil Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stomach Neoplasm |
| Intervention type | Drug |
| Interventions | irinotecan, cisplatin |
| Enrollment | 86 |
| Start date | Feb 1, 2005 |
| Completion | Mar 1, 2007 |
| First posted | May 3, 2006 |
| Last update posted | Mar 12, 2007 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: